Adkins, DE, Khachane, AN, Mcclay, JL, Aberg, K, Bukszar, J, Sullivan, PF and van den Oord, EJ (2012) SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study. Schizophrenia Research 135, 200–201.
Afkhami-Goli, A, Noorbakhsh, F, Keller, AJ, Vergnolle, N, Westaway, D, Jhamandas, JH, Andrade-Gordon, P, Hollenberg, MD, Arab, H, Dyck, RH and Power, C (2007) Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. Journal of Immunology 179, 5493–5503.
Alemany, S, Ribases, M, Vilor-Tejedor, N, Bustamante, M, Sanchez-Mora, C, Bosch, R, Richarte, V, Cormand, B, Casas, M, Ramos-Quiroga, JA and Sunyer, J (2015) New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 168, 459–470.
Amin, N, Belonogova, NM, Jovanova, O, Brouwer, RW, van Rooij, JG, van den Hout, MC, Svishcheva, GR, Kraaij, R, Zorkoltseva, IV, Kirichenko, AV, Hofman, A, Uitterlinden, AG, van Ijcken, WF, Tiemeier, H, Axenovich, TI and van Duijn, CM (2017 a) Nonsynonymous variation in NKPD1 increases depressive symptoms in European populations. Biological Psychiatry 81, 702–707.
Amin, N, Jovanova, O, Adams, HH, Dehghan, A, Kavousi, M, Vernooij, MW, Peeters, RP, de Vrij, FM, van der Lee, SJ, van Rooij, JG, van Leeuwen, EM, Chaker, L, Demirkan, A, Hofman, A, Brouwer, RW, Kraaij, R, Willems, VDK, Hankemeier, T, van Ijcken, WF, Uitterlinden, AG, Niessen, WJ, Franco, OH, Kushner, SA, Ikram, MA, Tiemeier, H and van Duijn, CM (2017 b) Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms. Molecular Psychiatry 22, 634.
Anderson, BJ (2011) Plasticity of gray matter volume: the cellular and synaptic plasticity that underlies volumetric change. Developmental Psychobiology 53, 456–465.
Anderson, GR, Galfin, T, Xu, W, Aoto, J, Malenka, RC and Sudhof, TC (2012) Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proceedings of the National Academy of Sciences of the USA 109, 18120–5.
Ashburner, J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38, 95–113.
Aston, C, Jiang, L and Sokolov, BP (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Molecular Psychiatry 10, 309–322.
Bah, TM, Benderdour, M, Kaloustian, S, Karam, R, Rousseau, G and Godbout, R (2011) Escitalopram reduces circulating pro-inflammatory cytokines and improves depressive behavior without affecting sleep in a rat model of post-cardiac infarct depression. Behavioural Brain Research 225, 243–251.
Baxter, MG (2009) Involvement of medial temporal lobe structures in memory and perception. Neuron 61, 667–677.
Berk, M, Williams, LJ, Jacka, FN, O'NEIL, A, Pasco, JA, Moylan, S, Allen, NB, Stuart, AL, Hayley, AC, Byrne, ML and Maes, M (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Medicine 11, 200.
Blalock, EM, Geddes, JW, Chen, KC, Porter, NM, Markesbery, WR and Landfield, PW (2004) Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proceedings of the National Academy of Sciences of the USA 101, 2173–2178.
Boulanger, LM (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64, 93–109.
Boyle, EA, Li, YI and Pritchard, JK (2017) An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186.
Buckner, RL, Andrews-Hanna, JR and Schacter, DL (2008) The brain's default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences 1124, 1–38.
Bulayeva, K, Lencz, T, Glatt, S, Takumi, T, Gurgenova, F, Kawakami, H and Bulayev, O (2012) Mapping genes related to early onset major depressive disorder in Dagestan genetic isolates. Turkish Journal of Psychiatry 23, 161–170.
Burkhardt, C, Muller, M, Badde, A, Garner, CC, Gundelfinger, ED and Puschel, AW (2005) Semaphorin 4B interacts with the post-synaptic density protein PSD-95/SAP90 and is recruited to synapses through a C-terminal PDZ-binding motif. FEBS Letters 579, 3821–3828.
Cao, X, Li, LP, Wang, Q, Wu, Q, Hu, HH, Zhang, M, Fang, YY, Zhang, J, Li, SJ, Xiong, WC, Yan, HC, Gao, YB, Liu, JH, Li, XW, Sun, LR, Zeng, YN, Zhu, XH and Gao, TM (2013) Astrocyte-derived ATP modulates depressive-like behaviors. Nature Medicine 19, 773–777.
Cazareth, J, Guyon, A, Heurteaux, C, Chabry, J and Petit-Paitel, A (2014) Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. Journal of Neuroinflammation 11, 132.
Chabry, J, Nicolas, S, Cazareth, J, Murris, E, Guyon, A, Glaichenhaus, N, Heurteaux, C and Petit-Paitel, A (2015) Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: relevance to depressive-like behavior. Brain, Behavior, and Immunity 50, 275–287.
Chen, J, Calhoun, VD and Liu, J (2012 a) ICA order selection based on consistency: application to genotype data. Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 2012, 360–363.
Chen, J, Calhoun, VD, Pearlson, GD, Ehrlich, S, Turner, JA, Ho, BC, Wassink, TH, Michael, AM and Liu, J (2012 b) Multifaceted genomic risk for brain function in schizophrenia. Neuroimage 61, 866–875.
Cohen-Woods, S, Craig, IW and Mcguffin, P (2013) The current state of play on the molecular genetics of depression. Psychological Medicine 43, 673–687.
CONVERGE Consortium (2015) Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523, 588–591.
Cusi, AM, Nazarov, A, Holshausen, K, Macqueen, GM and Mckinnon, MC (2012) Systematic review of the neural basis of social cognition in patients with mood disorders. Journal of Psychiatry Neuroscience 37, 154–169.
De Felipe, C, Herrero, JF, O'BRIEN, JA, Palmer, JA, Doyle, CA, Smith, AJ, Laird, JM, Belmonte, C, Cervero, F and Hunt, SP (1998) Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392, 394–397.
Djurovic, S, Gustafsson, O, Mattingsdal, M, Athanasiu, L, Bjella, T, Tesli, M, Agartz, I, Lorentzen, S, Melle, I, Morken, G and Andreassen, OA (2010) A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. Journal of Affective Disorder 126, 312–316.
Du, MY, Wu, QZ, Yue, Q, Li, J, Liao, Y, Kuang, WH, Huang, XQ, Chan, RC, Mechelli, A and Gong, QY (2012) Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 36, 11–16.
Elliott, LT, Sharp, K, Alfaro-Almagro, F, Shi, S, Miller, KL, Douaud, G, Marchini, J and Smith, SM (2018) Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature 562, 210–216.
First, M, Spitzer, R, Williams, J and Gibbons, M (1995a) Structured clinical interview for DSM-IV-Patient version. (Biometrics Research Department, New York State Psychiatric Institute).
First, M, Spitzer, R, Williams, J and Gibbons, M (1995b) Structured clinical interview for DSM-IV-non-patient edition (SCID-NP, Version). (American Psychological Association).
Gaynor, SM, Schwartz, J and Lin, X (2019) Mediation analysis for common binary outcomes. Statistics in Medicine 38, 512–529.
GBD 2015 DISEASE AND INJURY INCIDENCE AND PREVALENCE COLLABORATORS (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 388, 1545–1602.
Geracioti, TJ, Carpenter, LL, Owens, MJ, Baker, DG, Ekhator, NN, Horn, PS, Strawn, JR, Sanacora, G, Kinkead, B, Price, LH and Nemeroff, CB (2006) Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. American Journal of Psychiatry 163, 637–643.
Gibson, G (2012) Rare and common variants: twenty arguments. Nature Review Genetics 13, 135–145.
Gottesman, II and Gould, TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry 160, 636–645.
Gray, AL, Hyde, TM, Deep-Soboslay, A, Kleinman, JE and Sodhi, MS (2015) Sex differences in glutamate receptor gene expression in major depression and suicide. Molecular Psychiatry 20, 1139.
Guo, W, Liu, F, Xiao, C, Zhang, Z, Liu, J, Yu, M, Zhang, J and Zhao, J (2015) Decreased insular connectivity in drug-naive major depressive disorder at rest. Journal of Affective Disorder 179, 31–37.
Gupta, CN, Chen, J, Liu, J, Damaraju, E, Wright, C, Perrone-Bizzozero, NI, Pearlson, G, Luo, L, Michael, AM, Turner, JA and Calhoun, VD (2015) Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. Frontiers in Human Neuroscience 9, 100.
Hamilton, G, Evans, KL, Macintyre, DJ, Deary, IJ, Dominiczak, A, Smith, BH, Morris, AD, Porteous, DJ and Thomson, PA (2012) Alzheimer's disease risk factor complement receptor 1 is associated with depression. Neuroscience Letters 510, 6–9.
Hart, R and Greaves, DR (2010) Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. Journal of Immunology 185, 3728–3739.
Herbert, J and Lucassen, PJ (2016) Depression as a risk factor for Alzheimer's disease: genes, steroids, cytokines and neurogenesis – what do we need to know? Frontiers in Neuroendocrinology 41, 153–171.
Hoffman, P, Cox, SR, Dykiert, D, Munoz, MS, Valdes, HM, Bastin, ME, Wardlaw, JM and Deary, IJ (2017) Brain grey and white matter predictors of verbal ability traits in older age: the Lothian Birth Cohort 1936. Neuroimage 156, 394–402.
Hyde, CL, Nagle, MW, Tian, C, Chen, X, Paciga, SA, Wendland, JR, Tung, JY, Hinds, DA, Perlis, RH and Winslow, AR (2016) Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nature Genetics 48, 1031–1036.
Jagannathan, K, Calhoun, VD, Gelernter, J, Stevens, MC, Liu, J, Bolognani, F, Windemuth, A, Ruano, G, Assaf, M and Pearlson, GD (2010) Genetic associations of brain structural networks in schizophrenia: a preliminary study. Biological Psychiatry 68, 657–666.
Jansen, AG, Mous, SE, White, T, Posthuma, D and Polderman, TJ (2015) What twin studies tell us about the heritability of brain development, morphology, and function: a review. Neuropsychology Review 25, 27–46.
Jaracz, J, Gattner, K, Jaracz, K and Gorna, K (2016) Unexplained painful physical symptoms in patients with major depressive disorder: prevalence, pathophysiology and management. CNS Drugs 30, 293–304.
Ji, W, Li, T, Pan, Y, Tao, H, Ju, K, Wen, Z, Fu, Y, An, Z, Zhao, Q, Wang, T, He, L, Feng, G, Yi, Q and Shi, Y (2013) CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population. Psychiatry Research 207, 225–228.
Jun, G, Flickinger, M, Hetrick, KN, Romm, JM, Doheny, KF, Abecasis, GR, Boehnke, M and Kang, HM (2012) Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data. American Journal of Human Genetics 91, 839–848.
Kaminsky, EB, Kaul, V, Paschall, J, Church, DM, Bunke, B, Kunig, D, Moreno-De-luca, D, Moreno-De-luca, A, Mulle, JG, Warren, ST, Richard, G, Compton, JG, Fuller, AE, Gliem, TJ, Huang, S, Collinson, MN, Beal, SJ, Ackley, T, Pickering, DL, Golden, DM, Aston, E, Whitby, H, Shetty, S, Rossi, MR, Rudd, MK, South, ST, Brothman, AR, Sanger, WG, Iyer, RK, Crolla, JA, Thorland, EC, Aradhya, S, Ledbetter, DH and Martin, CL (2011) An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genetics Medicine 13, 777–784.
Karayannis, T, Au, E, Patel, JC, Kruglikov, I, Markx, S, Delorme, R, Heron, D, Salomon, D, Glessner, J, Restituito, S, Gordon, A, Rodriguez-Murillo, L, Roy, NC, Gogos, JA, Rudy, B, Rice, ME, Karayiorgou, M, Hakonarson, H, Keren, B, Huguet, G, Bourgeron, T, Hoeffer, C, Tsien, RW, Peles, E and Fishell, G (2014) Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature 511, 236–240.
Kelly, MA, Beuckmann, CT, Williams, SC, Sinton, CM, Motoike, T, Richardson, JA, Hammer, RE, Garry, MG and Yanagisawa, M (2005) Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain. Proceedings of the National Academy of Sciences of the USA 102, 9942–9947.
Khadka, S, Pearlson, GD, Calhoun, VD, Liu, J, Gelernter, J, Bessette, KL and Stevens, MC (2016) Multivariate imaging genetics study of MRI gray matter volume and SNPs reveals biological pathways correlated with brain structural differences in attention deficit hyperactivity disorder. Frontiers in Psychiatry 7, 128.
Kim, YK and Won, E (2017) The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder. Behavioural Brain Research 329, 6–11.
Kircher, M, Witten, DM, Jain, P, O'ROAK, BJ, Cooper, GM and Shendure, J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nature Genetics 46, 310–315.
Kohler, O, Benros, ME, Nordentoft, M, Farkouh, ME, Iyengar, RL, Mors, O and Krogh, J (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71, 1381–1391.
Kong, Y, Liang, X, Liu, L, Zhang, D, Wan, C, Gan, Z and Yuan, L (2015) High throughput sequencing identifies MicroRNAs mediating alpha-synuclein toxicity by targeting neuroactive-ligand receptor interaction pathway in early stage of drosophila Parkinson's disease model. PLoS ONE 10, e0137432.
Kraus, DM, Elliott, GS, Chute, H, Horan, T, Pfenninger, KH, Sanford, SD, Foster, S, Scully, S, Welcher, AA and Holers, VM (2006) CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. Journal of Immunology 176, 4419–4430.
Lai, CH (2013) Gray matter volume in major depressive disorder: a meta-analysis of voxel-based morphometry studies. Psychiatry Research 211, 37–46.
Lee, AC and Rudebeck, SR (2010) Investigating the interaction between spatial perception and working memory in the human medial temporal lobe. Journal of Cognitive Neuroscience 22, 2823–2835.
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics 45, 984–994.
Lener, MS and Iosifescu, DV (2015) In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. Annals of the New York Academy of Sciences 1344, 50–65.
Leonard, BE (2007) Inflammation, depression and dementia: are they connected? Neurochemical Research 32, 1749–1756.
Levinson, DF, Shi, J, Wang, K, Oh, S, Riley, B, Pulver, AE, Wildenauer, DB, Laurent, C, Mowry, BJ, Gejman, PV, Owen, MJ, Kendler, KS, Nestadt, G, Schwab, SG, Mallet, J, Nertney, D, Sanders, AR, Williams, NM, Wormley, B, Lasseter, VK, Albus, M, Godard-Bauche, S, Alexander, M, Duan, J, O'DONOVAN, MC, Walsh, D, O'NEILL, A, Papadimitriou, GN, Dikeos, D, Maier, W, Lerer, B, Campion, D, Cohen, D, Jay, M, Fanous, A, Eichhammer, P, Silverman, JM, Norton, N, Zhang, N, Hakonarson, H, Gao, C, Citri, A, Hansen, M, Ripke, S, Dudbridge, F and Holmans, PA (2012) Genome-wide association study of multiplex schizophrenia pedigrees. American Journal of Psychiatry 169, 963–973.
Li, M, Li, J, Li, MJ, Pan, Z, Hsu, JS, Liu, DJ, Zhan, X, Wang, J, Song, Y and Sham, PC (2017) Robust and rapid algorithms facilitate large-scale whole genome sequencing downstream analysis in an integrative framework. Nucleic Acids Research 45, e75.
Liberzon, A, Birger, C, Thorvaldsdottir, H, Ghandi, M, Mesirov, JP and Tamayo, P (2015) The molecular signatures database (MSigDB) hallmark gene set collection. Cell System 1, 417–425.
Liu, J, Demirci, O and Calhoun, VD (2008) A parallel independent component analysis approach to investigate genomic influence on brain function. IEEE Signal Processing Letters 15, 413–416.
Liu, J, Pearlson, G, Windemuth, A, Ruano, G, Perrone-Bizzozero, NI and Calhoun, V (2009) Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA. Hum Brain Mapping 30, 241–255.
Marsden, WN (2013) Synaptic plasticity in depression: molecular, cellular and functional correlates. Progress in Neuro-Psychopharmacology & Biological Psychiatry 43, 168–184.
Matsubara, T, Matsuo, K, Harada, K, Nakano, M, Nakashima, M, Watanuki, T, Egashira, K, Furukawa, M, Matsunaga, N and Watanabe, Y (2016) Distinct and shared endophenotypes of neural substrates in bipolar and major depressive disorders. PLoS ONE 11, e0168493.
Mcclay, JL, Adkins, DE, Aberg, K, Stroup, S, Perkins, DO, Vladimirov, VI, Lieberman, JA, Sullivan, PF and van den Oord, EJ (2011) Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. Molecular Psychiatry 16, 76–85.
Mckenna, A, Hanna, M, Banks, E, Sivachenko, A, Cibulskis, K, Kernytsky, A, Garimella, K, Altshuler, D, Gabriel, S, Daly, M and Depristo, MA (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research 20, 1297–1303.
Meda, SA, Ruano, G, Windemuth, A, O'NEIL, K, Berwise, C, Dunn, SM, Boccaccio, LE, Narayanan, B, Kocherla, M, Sprooten, E, Keshavan, MS, Tamminga, CA, Sweeney, JA, Clementz, BA, Calhoun, VD and Pearlson, GD (2014) Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proceedings of the National Academy of Sciences of the USA 111, E2066–E2075.
Montgomery, SA and Asberg, M (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382–389.
Muglia, P, Tozzi, F, Galwey, NW, Francks, C, Upmanyu, R, Kong, XQ, Antoniades, A, Domenici, E, Perry, J, Rothen, S, Vandeleur, CL, Mooser, V, Waeber, G, Vollenweider, P, Preisig, M, Lucae, S, Muller-Myhsok, B, Holsboer, F, Middleton, LT and Roses, AD (2010) Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Molecular Psychiatry 15, 589–601.
Nyman, ES, Sulkava, S, Soronen, P, Miettunen, J, Loukola, A, Leppa, V, Joukamaa, M, Maki, P, Jarvelin, MR, Freimer, N, Peltonen, L, Veijola, J and Paunio, T (2011) Interaction of early environment, gender and genes of monoamine neurotransmission in the aetiology of depression in a large population-based Finnish birth cohort. BMJ OPEN 1, e000087.
Palma, C and Manzini, S (1998) Substance P induces secretion of immunomodulatory cytokines by human astrocytoma cells. Journal of Neuroimmunology 81, 127–137.
Pearlson, GD, Liu, J and Calhoun, VD (2015) An introductory review of parallel independent component analysis (p-ICA) and a guide to applying p-ICA to genetic data and imaging phenotypes to identify disease-associated biological pathways and systems in common complex disorders. Frontiers in Genetics 6, 276.
Peng, D, Liddle, EB, Iwabuchi, SJ, Zhang, C, Wu, Z, Liu, J, Jiang, K, Xu, L, Liddle, PF, Palaniyappan, L and Fang, Y (2015) Dissociated large-scale functional connectivity networks of the precuneus in medication-naive first-episode depression. Psychiatry Research 232, 250–256.
Power, RA, Tansey, KE, Buttenschon, HN, Cohen-Woods, S, Bigdeli, T, Hall, LS, Kutalik, Z, Lee, SH, Ripke, S, Steinberg, S, Teumer, A, Viktorin, A, Wray, NR, Arolt, V, Baune, BT, Boomsma, DI, Borglum, AD, Byrne, EM, Castelao, E, Craddock, N, Craig, IW, Dannlowski, U, Deary, IJ, Degenhardt, F, Forstner, AJ, Gordon, SD, Grabe, HJ, Grove, J, Hamilton, SP, Hayward, C, Heath, AC, Hocking, LJ, Homuth, G, Hottenga, JJ, Kloiber, S, Krogh, J, Landen, M, Lang, M, Levinson, DF, Lichtenstein, P, Lucae, S, Macintyre, DJ, Madden, P, Magnusson, PK, Martin, NG, Mcintosh, AM, Middeldorp, CM, Milaneschi, Y, Montgomery, GW, Mors, O, Muller-Myhsok, B, Nyholt, DR, Oskarsson, H, Owen, MJ, Padmanabhan, S, Penninx, BW, Pergadia, ML, Porteous, DJ, Potash, JB, Preisig, M, Rivera, M, Shi, J, Shyn, SI, Sigurdsson, E, Smit, JH, Smith, BH, Stefansson, H, Stefansson, K, Strohmaier, J, Sullivan, PF, Thomson, P, Thorgeirsson, TE, Van der Auwera, S, Weissman, MM, Breen, G and Lewis, CM (2017) Genome-wide association for major depression through age at onset stratification: major depressive disorder working group of the psychiatric genomics consortium. Biological Psychiatry 81, 325–335.
Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D, Maller, J, Sklar, P, de Bakker, PI, Daly, MJ and Sham, PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 81, 559–575.
Purcell, SM, Moran, JL, Fromer, M, Ruderfer, D, Solovieff, N, Roussos, P, O'DUSHLAINE, C, Chambert, K, Bergen, SE, Kahler, A, Duncan, L, Stahl, E, Genovese, G, Fernandez, E, Collins, MO, Komiyama, NH, Choudhary, JS, Magnusson, PK, Banks, E, Shakir, K, Garimella, K, Fennell, T, Depristo, M, Grant, SG, Haggarty, SJ, Gabriel, S, Scolnick, EM, Lander, ES, Hultman, CM, Sullivan, PF, Mccarroll, SA and Sklar, P (2014) A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190.
Putnam, DK, Sun, J and Zhao, Z (2011) Exploring schizophrenia drug-gene interactions through molecular network and pathway modeling. AMIA Annual Symposium Proceedings 2011, 1127–1133.
Rameshwar, P, Gascon, P and Ganea, D (1992) Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance p. Journal of Neuroimmunology 37, 65–74.
Rietschel, M, Mattheisen, M, Frank, J, Treutlein, J, Degenhardt, F, Breuer, R, Steffens, M, Mier, D, Esslinger, C, Walter, H, Kirsch, P, Erk, S, Schnell, K, Herms, S, Wichmann, HE, Schreiber, S, Jockel, KH, Strohmaier, J, Roeske, D, Haenisch, B, Gross, M, Hoefels, S, Lucae, S, Binder, EB, Wienker, TF, Schulze, TG, Schmal, C, Zimmer, A, Juraeva, D, Brors, B, Bettecken, T, Meyer-Lindenberg, A, Muller-Myhsok, B, Maier, W, Nothen, MM and Cichon, S (2010) Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biological Psychiatry 68, 578–585.
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Molecular Psychiatry 18, 497–511.
Ryan, JJ, Weilage, ME and Spaulding, WD (1999) Accuracy of the seven subtest WAIS-R short form in chronic schizophrenia. Schizophria Research 39, 79–83.
Schafer, DP, Lehrman, EK, Kautzman, AG, Koyama, R, Mardinly, AR, Yamasaki, R, Ransohoff, RM, Greenberg, ME, Barres, BA and Stevens, B (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691–705.
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427.
Schmaal, L, Hibar, DP, Samann, PG, Hall, GB, Baune, BT, Jahanshad, N, Cheung, JW, van Erp, TG, Bos, D, Ikram, MA, Vernooij, MW, Niessen, WJ, Tiemeier, H, Hofman, A, Wittfeld, K, Grabe, HJ, Janowitz, D, Bulow, R, Selonke, M, Volzke, H, Grotegerd, D, Dannlowski, U, Arolt, V, Opel, N, Heindel, W, Kugel, H, Hoehn, D, Czisch, M, Couvy-Duchesne, B, Renteria, ME, Strike, LT, Wright, MJ, Mills, NT, de Zubicaray, GI, Mcmahon, KL, Medland, SE, Martin, NG, Gillespie, NA, Goya-Maldonado, R, Gruber, O, Kramer, B, Hatton, SN, Lagopoulos, J, Hickie, IB, Frodl, T, Carballedo, A, Frey, EM, van Velzen, LS, Penninx, BW, van Tol, MJ, van der Wee, NJ, Davey, CG, Harrison, BJ, Mwangi, B, Cao, B, Soares, JC, Veer, IM, Walter, H, Schoepf, D, Zurowski, B, Konrad, C, Schramm, E, Normann, C, Schnell, K, Sacchet, MD, Gotlib, IH, Macqueen, GM, Godlewska, BR, Nickson, T, Mcintosh, AM, Papmeyer, M, Whalley, HC, Hall, J, Sussmann, JE, Li, M, Walter, M, Aftanas, L, Brack, I, Bokhan, NA, Thompson, PM and Veltman, DJ (2016) Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA major depressive disorder working group. Molecular Psychiatry 22, 900–909.
Sekar, A, Bialas, AR, de Rivera, H, Davis, A, Hammond, TR, Kamitaki, N, Tooley, K, Presumey, J, Baum, M, Van Doren, V, Genovese, G, Rose, SA, Handsaker, RE, Daly, MJ, Carroll, MC, Stevens, B and Mccarroll, SA (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183.
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R and Dunbar, GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59(suppl. 20), 22–33;quiz 34-57.
Shen, Z, Cheng, Y, Yang, S, Dai, N, Ye, J, Liu, X, Lu, J, Li, N, Liu, F, Lu, Y, Sun, X and Xu, X (2016) Changes of grey matter volume in first-episode drug-naive adult major depressive disorder patients with different age-onset. Neuroimage Clinical 12, 492–498.
Shi, J, Johansson, J, Woodling, NS, Wang, Q, Montine, TJ and Andreasson, K (2010) The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. Journal of Immunology 184, 7207–7218.
Shi, J, Potash, JB, Knowles, JA, Weissman, MM, Coryell, W, Scheftner, WA, Lawson, WB, Depaulo, JJ, Gejman, PV, Sanders, AR, Johnson, JK, Adams, P, Chaudhury, S, Jancic, D, Evgrafov, O, Zvinyatskovskiy, A, Ertman, N, Gladis, M, Neimanas, K, Goodell, M, Hale, N, Ney, N, Verma, R, Mirel, D, Holmans, P and Levinson, DF (2011) Genome-wide association study of recurrent early-onset major depressive disorder. Molecular Psychiatry 16, 193–201.
Singh, T, Walters, J, Johnstone, M, Curtis, D, Suvisaari, J, Torniainen, M, Rees, E, Iyegbe, C, Blackwood, D, Mcintosh, AM, Kirov, G, Geschwind, D, Murray, RM, Di Forti, M, Bramon, E, Gandal, M, Hultman, CM, Sklar, P, Palotie, A, Sullivan, PF, O'DONOVAN, MC, Owen, MJ and Barrett, JC (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nature Genetics 49, 1167–1173.
Steen, VM, Nepal, C, Ersland, KM, Holdhus, R, Naevdal, M, Ratvik, SM, Skrede, S and Havik, B (2013) Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. PLoS ONE 8, e79501.
Stevens, B, Allen, NJ, Vazquez, LE, Howell, GR, Christopherson, KS, Nouri, N, Micheva, KD, Mehalow, AK, Huberman, AD, Stafford, B, Sher, A, Litke, AM, Lambris, JD, Smith, SJ, John, SW and Barres, BA (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164–1178.
Stockmeier, CA, Shi, X, Konick, L, Overholser, JC, Jurjus, G, Meltzer, HY, Friedman, L, Blier, P and Rajkowska, G (2002) Neurokinin-1 receptors are decreased in major depressive disorder. Neuroreport 13, 1223–1227.
Sullivan, PF, Daly, MJ and O'DONOVAN, M (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nature Review Genetics 13, 537–551.
Tammimies, K, Marshall, CR, Walker, S, Kaur, G, Thiruvahindrapuram, B, Lionel, AC, Yuen, RK, Uddin, M, Roberts, W, Weksberg, R, Woodbury-Smith, M, Zwaigenbaum, L, Anagnostou, E, Wang, Z, Wei, J, Howe, JL, Gazzellone, MJ, Lau, L, Sung, WW, Whitten, K, Vardy, C, Crosbie, V, Tsang, B, D'ABATE, L, Tong, WW, Luscombe, S, Doyle, T, Carter, MT, Szatmari, P, Stuckless, S, Merico, D, Stavropoulos, DJ, Scherer, SW and Fernandez, BA (2015) Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children With autism Spectrum disorder. JAMA 314, 895–903.
Tammiste, A, Jiang, T, Fischer, K, Magi, R, Krjutskov, K, Pettai, K, Esko, T, Li, Y, Tansey, KE, Carroll, LS, Uher, R, Mcguffin, P, Vosa, U, Tsernikova, N, Saria, A, Ng, PC, Eller, T, Vasar, V, Nutt, DJ, Maron, E, Wang, J and Metspalu, A (2013) Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression. Journal of Psychopharmacology 27, 915–920.
Terracciano, A, Tanaka, T, Sutin, AR, Sanna, S, Deiana, B, Lai, S, Uda, M, Schlessinger, D, Abecasis, GR, Ferrucci, L and Costa, PJ (2010) Genome-wide association scan of trait depression. Biological Psychiatry 68, 811–817.
Tombacz, D, Maroti, Z, Kalmar, T, Csabai, Z, Balazs, Z, Takahashi, S, Palkovits, M, Snyder, M and Boldogkoi, Z (2017) High-coverage whole-exome sequencing identifies candidate genes for suicide in victims with major depressive disorder. Scientific Report 7, 7106.
Uddin, LQ, Kelly, AM, Biswal, BB, Castellanos, FX and Milham, MP (2009) Functional connectivity of default mode network components: correlation, anticorrelation, and causality. Human Brain Mapping 30, 625–637.
Vassilatis, DK, Hohmann, JG, Zeng, H, Li, F, Ranchalis, JE, Mortrud, MT, Brown, A, Rodriguez, SS, Weller, JR, Wright, AC, Bergmann, JE and Gaitanaris, GA (2003) The G protein-coupled receptor repertoires of human and mouse. Proceedings of the National Academy of Sciences of the USA 100, 4903–4908.
Wagner, K, Uherek, M, Horstmann, S, Kadish, NE, Wisniewski, I, Mayer, H, Buschmann, F, Metternich, B, Zentner, J and Schulze-Bonhage, A (2013) Memory outcome after hippocampus sparing resections in the temporal lobe. Journal of Neurology, Neurosurgery, and Psychiatry 84, 630–636.
Wainwright, SR and Galea, LA (2013) The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plasticity 2013, 805497.
Wray, NR, Pergadia, ML, Blackwood, DH, Penninx, BW, Gordon, SD, Nyholt, DR, Ripke, S, Macintyre, DJ, Mcghee, KA, Maclean, AW, Smit, JH, Hottenga, JJ, Willemsen, G, Middeldorp, CM, de Geus, EJ, Lewis, CM, Mcguffin, P, Hickie, IB, van den Oord, EJ, Liu, JZ, Macgregor, S, Mcevoy, BP, Byrne, EM, Medland, SE, Statham, DJ, Henders, AK, Heath, AC, Montgomery, GW, Martin, NG, Boomsma, DI, Madden, PA and Sullivan, PF (2012) Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Molecular Psychiatry 17, 36–48.
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium (2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nature Genetics 50, 668–681.
Yamamoto, T, Saito, O, Shono, K and Tanabe, S (2005) Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats. Brain Research 1045, 97–106.
Yang, LM, Yu, L, Jin, HJ and Zhao, H (2014) Substance P receptor antagonist in lateral habenula improves rat depression-like behavior. Brain Research Bulletin 100, 22–28.
Zeng, LL, Shen, H, Liu, L, Fang, P, Liu, Y and Hu, D (2015) State-dependent and trait-related gray matter changes in nonrefractory depression. Neuroreport 26, 57–65.
Zhan, X, Hu, Y, Li, B, Abecasis, GR and Liu, DJ (2016) RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics (Oxford, England) 32, 1423–1426.
Zhang, H, Li, L, Wu, M, Chen, Z, Hu, X, Chen, Y, Zhu, H, Jia, Z and Gong, Q (2016 a) Brain gray matter alterations in first episodes of depression: a meta-analysis of whole-brain studies. Neuroscience and Biobehavioral Review 60, 43–50.
Zhang, Y, Catts, VS, Sheedy, D, Mccrossin, T, Kril, JJ and Shannon, WC (2016 b) Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Translational Psychiatry 6, e982.
Zhu, W, Chen, Q, Xia, L, Beaty, RE, Yang, W, Tian, F, Sun, J, Cao, G, Zhang, Q, Chen, X and Qiu, J (2017) Common and distinct brain networks underlying verbal and visual creativity. Human Brain Mapping 38, 2094–2111.
Zorrilla, EP, Luborsky, L, Mckay, JR, Rosenthal, R, Houldin, A, Tax, A, Mccorkle, R, Seligman, DA and Schmidt, K (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain, Behavior, and Immunity 15, 199–226.